European Palliative Care Research Centre, Faculty of Medicine, NTNU, NO-7006 Trondheim, Norway.
Eur J Pain. 2011 Mar;15(3):320-7. doi: 10.1016/j.ejpain.2010.08.001. Epub 2010 Sep 6.
This study is part of a research program to reach consensus on an international cancer pain classification system. A confirmative and explorative approach was applied to investigate which of the variables identified in the literature, by experts and patients that are associated with pain.
Data from an international, multicentre, cross-sectional study of cancer patients treated with opioids were investigated. Dependent variables were: average pain, worst pain, and pain relief (11-point Numerical Rating Scales). Forty-six independent variables were chosen based upon previous studies. Bivariate analyses identified independent variables associated with at least one of the dependent ones; 21 were included in multivariate linear regression analyses.
Two thousand two hundred and seventy-eight patients were investigated; 52% males, mean age 62 years, mean Karnofsky Performance Status 59%, mean daily opioid oral equivalent dose 341 mg. Fifty-eight percent had breakthrough pain. Mean pain scores were: average pain 3.5, worst pain 5.3 and pain relief 74%. Variables most strongly associated with these three dependent variables were: breakthrough pain, psychological distress, sleep, and opioid dose.
Breakthrough pain and psychological distress were confirmed as key variables of a future classification system. Candidate variables were: sleep, opioid dose, pain mechanism, use of non-opioids, pain localisation, cancer diagnosis, location of metastases, and addiction.
本研究是达成国际癌症疼痛分类系统共识的研究计划的一部分。采用验证性和探索性方法,调查文献中、专家和患者确定的与疼痛相关的变量中,哪些变量与疼痛相关。
对接受阿片类药物治疗的癌症患者的国际多中心横断面研究数据进行调查。因变量为:平均疼痛、最剧烈疼痛和疼痛缓解(11 点数字评分量表)。根据以往研究,选择了 46 个独立变量。双变量分析确定与至少一个因变量相关的独立变量;21 个变量纳入多变量线性回归分析。
共调查了 2278 例患者;男性占 52%,平均年龄 62 岁,平均 Karnofsky 表现状态 59%,平均每日阿片类药物口服等效剂量 341mg。58%的患者有爆发性疼痛。平均疼痛评分分别为:平均疼痛 3.5,最剧烈疼痛 5.3,疼痛缓解 74%。与这三个依赖变量最密切相关的变量为:爆发性疼痛、心理困扰、睡眠和阿片类药物剂量。
爆发性疼痛和心理困扰被确认为未来分类系统的关键变量。候选变量包括:睡眠、阿片类药物剂量、疼痛机制、非阿片类药物的使用、疼痛定位、癌症诊断、转移部位和成瘾。